Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07394478

Study of the Association Between Sacroiliitis/Axial Spondylarthritis and Giant Cell Arteritis/ Polymyalgia Rheumatica

Study of the Association Between Sacroiliitis/Axial Spondylarthritis and Giant Cell Arteritis/ Polymyalgia Rheumatica: A Case-control Observational Study

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
10 (estimated)
Sponsor
Hôpital NOVO · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to recruit as many patients as possible presenting with sacroiliitis or authentic axial spondylarthritis and giant cell arteritis. The investigators will also be interested in the association of spondylarthritis and polymyalgia rheumatica given the continuum between these two pathologies. The aim is to investigate whether there is an association between giant cell arteritis and spondylarthritis or polymyalgia rheumatica and spondylarthritis.

Detailed description

Large vessel vasculitis primarily includes Takayasu's arteritis and Giant Cell Arteritis (GCA). The literature describes associations between spondyloarthritis and large vessel vasculitis, particularly with Takayasu's arteritis. Case reports have highlighted specific features in patients presenting with both conditions, such as an older age at spondyloarthritis diagnosis and higher C-reactive protein (CRP) levels, for example. However, to date, no cases of axial spondyloarthritis associated with confirmed GCA have been reported in the literature. The investigators plan to recruit cases (patients with GCA and/or polymyalgia rheumatica \[PMR\] plus spondyloarthritis) and controls (patients with GCA or PMR alone). The investigators will then analyze their characteristics to investigate a potential association between these diseases.

Conditions

Interventions

TypeNameDescription
OTHERDescription of populationDescription of population in the aim of identify demographic or phenotypic factors different between experimental and control populations.

Timeline

Start date
2026-02-01
Primary completion
2026-06-30
Completion
2026-06-30
First posted
2026-02-06
Last updated
2026-02-06

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT07394478. Inclusion in this directory is not an endorsement.